A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and ...

I’m wondering if any studies explain this and what’s the best way to address it. Should I increase the dose further or switch ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

Given Wegovy’s success and record-high sales, a wave of investments has gone into the obesity space over the last couple of ...

New Delhi: Eli Lilly’s Zepbound drug holds potential to dominate the global obesity market due to its superior efficacy and ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...

The holidays can be a difficult time for those with a history of eating disorders, and having someone comment on their body – ...

Drugs are arriving that cure the urge to overeat, drink and smoke. Thank goodness for that - it's time to stop blaming humans ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20 percent of their body weight, on average, a result that caused the Danish company’s ...

The market is obsessed with risky options, but disciplined investors know slow and steady wins. Check out three stock picks ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Junk food companies are starting to get nervous over how many Americans use GLP-1 medications to lose weight. Washington Post ...